| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Novo Holdings A/S | 10%+ Owner | $22.6M | Feb 23, 2022 | ||
| venBio Global Strategic Fund II L.P. | 10%+ Owner | $22.5M | May 13, 2022 | ||
| Arthur M. Krieg | Chief Scientific Officer | $8.52M | Jun 18, 2021 | ||
| James Wooldridge | Chief Medical Officer | May 31, 2022 | |||
| Robert Dolski | Chief Financial Officer | May 31, 2022 | |||
| Joy Yan | Director | May 31, 2022 | |||
| Alan Bash | Chief Executive Officer, Director | May 31, 2022 | |||
| Barry Labinger | President and CEO, Director | Aug 4, 2021 | |||
| Alan Fuhrman | Director | May 31, 2022 | |||
| Michael Powell | Director | May 31, 2022 | |||
| Jon Marc Wigginton | Director | May 31, 2022 | |||
| Peter Colabuono | Director | May 31, 2022 | |||
| Keith T. Flaherty | Director | May 31, 2022 | |||
| Oren Isacoff | Director | May 31, 2022 | |||
| Kleem Chaudhary | Chief Business Officer | Aug 4, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|